Literature DB >> 6450893

[Oral treatment of severe forms of acne with 13-cis-retinoic acid. Clinical results (author's transl)].

G Plewig, A Wagner, O Braun-Falco.   

Abstract

A new, very effective method of treating severe forms of acne (papuplopustular, conglobate, fulminating and tetrad) is the oral administration of 13-cis-retinoic acid. The results described by Peck et al. (1979) in 14 patients are demonstrated in detail in 18 patients. In the initial therapy 1 to 2 mg/kg body weight were administered daily for 12 weeks without any other local or systemic treatment. In the second phase of the study half the patients continued treatment with 0.5 mg/kg body weight 13-cis-retinoic acid, the other half remaining without any further therapy. All inflammatory lesions healed after 12-16 weeks, sebum production was largely reduced. 13-cis-retinoic acid represents a remarkable turn in the treatment of most severe acne.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6450893

Source DB:  PubMed          Journal:  MMW Munch Med Wochenschr        ISSN: 0341-3098


  8 in total

1.  Professor Dr. Dr. h. c. Otto Braun-Falco.

Authors: 
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

Review 2.  The retinoids. A review of their clinical pharmacology and therapeutic use.

Authors:  C E Orfanos; R Ehlert; H Gollnick
Journal:  Drugs       Date:  1987-10       Impact factor: 9.546

3.  13-cis-retinoic acid in conglobate acne. A follow-up study of 14 trial centers.

Authors:  R Hennes; A Mack; H Schell; H J Vogt
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

4.  Reduction of bacterial skin flora during oral treatment of severe acne with 13-cis retinoic acid.

Authors:  A Weissmann; A Wagner; G Plewig
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

5.  Effect of 13-cis-retinoic acid on sebum production and Propionibacterium acnes in severe nodulocystic acne.

Authors:  J J Leyden; K J McGinley
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

6.  Anti-inflammatory effects of 13-Cis-retinoic acid. An in vivo study.

Authors:  G Plewig; A Wagner
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

7.  Inhibitory effects of 13-cis-retinoic acid on human sebaceous glands.

Authors:  M Landthaler; J Kummermehr; A Wagner; G Plewig
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

8.  Treatment of gram-negative folliculitis with isotretinoin.

Authors:  U Neubert; G Plewig; A Ruhfus
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.